Skip to main content
    S

    Si-Bone Inc (SIBN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $23.44
    -0.70 (-2.90%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Si-Bone Inc (SIBN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 2, 2026. Financial statements from company filings, amounts in US dollars.

    Si-Bone reported revenue of $200.93M for the fiscal year ended Dec 31, 2025, up 20.2% from the year before. That year, net income was -$18.90M with a net margin of -9.4%, operating cash flow was -$675.00K and free cash flow was -$9.09M. The quarter ended Sep 30, 2026 had revenue of $55.70M and net income of -$3.62M.

    Revenue and Margins

    The operating margin was -11.1% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $42.10M, a compound annual rate of 19.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$200.93M+20.2%79.6%-11.1%-9.4%
    Dec 2024$167.18M+20.4%79.0%-21.1%-18.5%
    Dec 2023$138.89M+30.5%78.8%-33.8%-31.2%
    Dec 2022$106.41M+18.0%85.2%-56.0%-57.6%
    Dec 2021$90.15M+22.8%88.4%-57.3%-62.8%
    Dec 2020$73.39M+9.0%87.9%-52.6%-59.5%
    Dec 2019$67.30M+21.5%89.9%-53.5%-57.1%
    Dec 2018$55.38M+15.4%91.3%-21.6%-31.5%
    Dec 2017$47.98M+14.0%89.3%-36.2%-48.0%
    Dec 2016$42.10MN/A87.7%-41.7%-48.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$200.93M$167.18M$138.89M$106.41M$90.15M$73.39M$67.30M$55.38M$47.98M$42.10M
    Cost of revenue$41.05M$35.06M$29.47M$15.71M$10.43M$8.90M$6.79M$4.83M$5.11M$5.17M
    Gross profit$159.88M$132.12M$109.42M$90.70M$79.72M$64.48M$60.51M$50.55M$42.87M$36.94M
    Research and development$17.45M$16.56M$15.03M$13.63M$12.44M$9.46M$7.28M$5.38M$5.51M$6.38M
    Operating income-$22.33M-$35.25M-$46.93M-$59.61M-$51.67M-$38.57M-$36.00M-$11.96M-$17.35M-$17.57M
    Net income-$18.90M-$30.91M-$43.34M-$61.26M-$56.57M-$43.70M-$38.40M-$17.45M-$23.04M-$20.59M
    EBITDA-$19.51MN/A-$45.16M-$55.73M-$47.73M-$37.16MN/AN/A-$15.71M-$16.24M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$55.70M$56.01M$52.59M$56.35M$48.66M$48.63M$47.29M$49.00M$40.34M$39.97M$37.87M$38.86M
    Gross profit$44.17M$44.55M$41.94M$44.53M$38.85M$38.81M$37.70M$38.78M$31.90M$31.58M$29.86M$28.68M
    Operating income-$4.35M-$4.81M-$5.09M-$2.46M-$5.38M-$7.00M-$7.48M-$5.49M-$7.63M-$10.08M-$12.04M-$12.51M
    Net income-$3.62M-$4.09M-$4.33M-$1.64M-$4.57M-$6.15M-$6.54M-$4.50M-$6.58M-$8.94M-$10.90M-$10.98M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $36.51M by $5.73M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$238.56M$230.44M$230.43M$157.55M$190.51M$223.14M$117.01M$138.52M$35.83M$39.44M
    Current assets$216.12M$207.78M$211.39M$137.61M$175.87M$218.24M$111.46M$136.04M$33.63M$36.32M
    Cash and equivalents$42.24M$34.95M$33.27M$20.72M$63.42M$53.58M$10.44M$25.12M$22.41M$27.90M
    Total liabilities$61.02M$63.47M$61.05M$59.25M$56.09M$53.78M$54.00M$48.33M$46.66M$148.17M
    Short-term debt$944.00K$1.15M$1.42M$1.39M$1.34MN/A$4.36M$0$38.70M$8.24M
    Long-term debt$35.57M$35.45M$36.06M$35.17M$34.97M$39.45M$34.87M$38.96M$38.70M$21.07M
    Shareholder equity$177.53M$166.96M$169.38M$98.30M$134.42M$169.36M$63.01M$90.19M-$129.38M-$108.73M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$256.77M$248.76M$242.72M$238.56M$234.27M$230.92M$227.28M$230.44M$227.00M$223.84M$223.71M$230.43M
    Total liabilities$72.09M$66.41M$63.78M$61.02M$62.15M$60.58M$60.02M$63.47M$62.02M$59.11M$58.18M$61.05M
    Cash and equivalents$35.31M$33.13M$33.53M$42.24M$26.49M$34.15M$41.19M$34.95M$30.23M$25.58M$32.04M$33.27M
    Shareholder equity$184.68M$182.35M$178.94M$177.53M$172.13M$170.34M$167.26M$166.96M$164.97M$164.73M$165.54M$169.38M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$675.00K-$12.43M-$18.71M-$41.66M-$39.53M-$30.66M-$31.63M-$14.52M-$17.53M-$16.75M
    Capital expenditures$8.41M$10.50M$7.80M$9.51M$6.39M$2.56M$2.44M$942.00K$478.00K$441.00K
    Free cash flow-$9.09M-$22.92M-$26.51M-$51.16M-$45.92M-$33.22M-$34.07M-$15.46M-$18.01M-$17.19M
    Dividends paidN/AN/A$2.15MN/A$4.91M$1.92MN/AN/AN/AN/A
    Share repurchasesN/AN/AN/AN/AN/AN/A$167.00K$1.97M$1.29MN/A
    Investing cash flow$4.16M$12.62M-$59.80M-$2.81M$51.58M-$62.92M$13.49M-$97.83M-$478.00K-$441.00K
    Financing cash flow$3.38M$1.96M$90.93M$2.20M-$1.71M$136.40M$3.49M$115.15M$12.86M$24.75M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$5.94M$777.00K-$2.36M$1.73M$2.33M$173.00K-$4.91M$1.18M$302.00K-$6.33M-$7.57M-$2.30M
    Capital expenditures$6.37M$1.54M$1.08M$1.29M$2.96M$2.10M$2.07M$2.27M$3.04M$3.11M$2.08M$1.09M
    Free cash flow-$427.00K-$768.00K-$3.44M$440.00K-$620.00K-$1.93M-$6.98M-$1.09M-$2.73M-$9.45M-$9.65M-$3.39M
    Last 12 quarters

    Frequently Asked Questions About SIBN

    What is Si-Bone's annual revenue?

    Si-Bone reported revenue of $200.93M for the fiscal year ended Dec 31, 2025.

    How fast is Si-Bone's revenue growing?

    Revenue was up 20.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 23.6%.

    Is Si-Bone profitable?

    No. Si-Bone reported net income of -$18.90M for the fiscal year ended Dec 31, 2025, with a net margin of -9.4%.

    How much free cash flow does SIBN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$675.00K minus capital expenditures of $8.41M produced free cash flow of -$9.09M.

    How much debt does Si-Bone have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $35.57M, short-term debt of $944.00K and cash and equivalents of $42.24M.